Temsirolimus Kit
Product Images NDC 68083-202

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Temsirolimus (NDC 68083-202). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Temsirolimus-spl-carton-label (Temsirolimus Spl Carton Label)

This is a product description of Temsirolimus Injection. It is a concentrated medication that requires two dilutions before injection. Each single dose vial contains 25mg/mL and should only be administered through IV infusion. The package includes two types of single-dose vials, one containing 25mg of Temsirolimus Injection and another containing 4 doses. The medication must be refrigerated, and its concentration is 10mg/mL after dilution.*

FDA Label Image

Temsirolimus-spl-diluent-label1 (Temsirolimus Spl Diluent Label1)

This is a description of a medication diluent with the National Drug Code 68083.201.01 for diluting temsirolimus injection vial. It is a prescription-based medication that comes in a 2.2mL vial with instructions not to be used for direct administration. The product should only be used for the purpose of diluting temsirolimus injection vial and should be refrigerated.*

FDA Label Image

Temsirolimus-spl-graph1 (Temsirolimus Spl Graph1)

FDA Label Image

Temsirolimus-spl-product-label1 (Temsirolimus Spl Product Label1)

FDA Label Image

Temsirolimus-spl-structure (Temsirolimus Spl Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.